A group of AMMREN journalists from Ghana and Burkina Faso visited the Kintampo Health Research Centre (KHRC) in Ghana for the Phase III vaccine trial on 1st and 2nd September, 2009.. The Kintampo Research Centre is among 11 research centres in seven African countries selected to conduct the vaccine trials..

The vaccine has already gone through its first and second phases of trials and it has been found to be safe. A total of 16,000 children in the seven African countries would be taking part in the trials to test the efficacy of the vaccine.

Launching the vaccine, the Brong Ahafo Regional Director of Health Service, Dr. Aaron Offei, said that the selection KHRC to be part of the malaria vaccine trial showed how efficient the centre is and called on the people in the community to assist the centre to be successful in its activities.

Dr. Seth Owusu-Agyei, Director, KHRC briefing AMMREN members before the launch.